Gulf Funds Agree to Back Paramount's Takeover of Warner; Netflix Upgraded; Neurocrine to Buy Soleno Therapeutics
Audio is streamed directly from the publisher (podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Gulf Funds Agree to Back Paramount's $81 Billion Takeover of Warner
- Netflix (NFLX) shares are up after Goldman Sachs upgraded the streaming-video company to buy from neutral.
- Neurocrine Biosciences agreed to buy Soleno Therapeutics for $2.9 billion to expand in rare genetic disorders. The biotechnology company will pay $53 per share for Soleno, a 34% premium to its closing share price Thursday, using cash on hand and some pre-payable debt. Both company boards have approved the transaction, which is expected to close within 90 days.
See omnystudio.com/listener for privacy information.